Effect of Lewis y antigen on regulating gene expression of partial drug resistance associated proteins in human ovarian cancer cell line RMG-I-H

Acta Academiae Medicinae Sinicae

Volumn 31, Issue 4, 2009, Pages 481-487

  Liu, Qing ^a   Lin, Bei ^a   Wang, Peng Li ^a   Yan, Li Mei ^a   Hao, Ying Ying ^a   Li, Fei Fei ^a   Zhu, Lian Cheng ^a   Zhang, Shu Lan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance associated proteins; Lewis y antigen; Lewis y monoclonal antibody; Ovarian cancer

Indexed keywords

DNA TOPOISOMERASE; FUCOSYLTRANSFERASE; GLYCOPROTEIN P; MESSENGER RNA; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PROTEIN KINASE C ALPHA; SYNAPSIN I; BLOOD GROUP LEWIS SYSTEM; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; LEWIS Y ANTIGEN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; TOP1 PROTEIN, HUMAN;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOCHEMISTRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CANCER; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL LINE; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; MULTIDRUG RESISTANCE; NUDE MOUSE; OVARY TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FUCOSYLTRANSFERASES; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MICE; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; TRANSFECTION;

EID: 70350493516     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2009.04.020     Document Type: Article

References (25)

1. Iwamori M, Tanoka K, Kubushiro K, et al. Alterations in the glycolipid compositon and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha 1, 2-fucosyltransferase gene [J]. Cancer Sci, 2005, 96 (1):26-30. (Pubitemid 40310021)
2. Reinecke P, Knopf C, Schmitz M, et al. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype [J]. Cancer, 2000, 88(7):1614-1622. (Pubitemid 30183147)
3. Shoda J, Kano M, Oda K, et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function [J]. Am J Gastroenterol, 2001, 96(12):3368-3378. (Pubitemid 34016662)
4. Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor [J]. Cells Biochemistry (Moscow), 2000, 65(1):95-106.
5. Zhan M, Yu D, Liu J, et al. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation [J]. J Biol Chem, 2005, 280(6):4825-4833. (Pubitemid 40288655)
6. Naniwa J, Kigawa J, Kanamori Y, et al. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer [J]. Int J Gynecol Cancer, 2007, 17(1): 76-82. (Pubitemid 46213973)
7. Kudo T, Nakagawa H, Takahashi M, et al. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma [J]. Mol Cancer, 2007, 6(32):1-9. (Pubitemid 46864037)
8. Kiguchi K, Iwamori Y, Suzuki N, et al. Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance [J]. Cancer Sci, 2006, 97(12):1321-1326. (Pubitemid 44614983)
9. Iwamori M, Iwamori Y, Kubushiro K, et al. Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-devrived cells with anticancer drug-resistance [J]. J Biochem, 2007, 141(3):309-317. (Pubitemid 46770383)
10. Bsau A, Murthy U, Rodecd U, et al. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas [J]. Cancer Res, 1987, 47 (10):2531-2536. (Pubitemid 17083135)
11. Garcia R, Franklin RA, McCubrey JA, et al. EGF induces cell motility and mutidrug resistance gene expressionin breast cancer cells [J]. Cell Cycle, 2006, 5(23):2820-2826. (Pubitemid 44901745)
12. Venugopal J, Hanashiro K, Yang ZZ, et al. Identification and modulation of a caveolae-dependendent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes [J]. Proc Natl Acad Sci USA, 2004, 101(49):17120-17125. (Pubitemid 39627784)
13. Lee HH, Chiang WH, Chiang SH, et al. Regulation of cyclin D1, DNA topoiso-merase I, and proliferating cell nuclear antigen promoters during the cell cycle [J]. Gene Expr, 1995, 4(3):95-109.
14. Ohashi R, Takahashi F, Cui R, et al. Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell [J]. Cancer Lett, 2007, 252(2): 225-234. (Pubitemid 46809789)
15. Tsujimura S, Saito K, Kohno K, et al. Fragmented hyaluronan induces transcriptional up-regulation of the multidrug resistance-1 gene in CD4 + T cells [J]. J Biol Chem, 2006, 281(49):38089-38097. (Pubitemid 46042112)
16. Bourguignon LY, Gilad E, Rothman K, et al. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation and ovarian cancer progression [J]. J Biol Chem, 2005, 280(12):11961-11972. (Pubitemid 40418513)
17. Ying TH, Hsieh YH, Hsieh YS, et al. Antisense oligonucleotide Elk-1 supression the tumorigenicity of human hepatocellular carcinoma cells [J]. Cell Biol Int, 2008, 32(2):210-216.
18. Wang QY, Zhang Y, Chen HJ, et al. Alpha 1, 3-fucosyltransferase-VII regulates the signaling molecules of the insulin receptor pathway [J]. FEBS J, 2007, 274(2):526-538. (Pubitemid 46046660)
19. Simons K, Ikonen E. Functional rafts in cell membranes [J]. Nature, 1997, 387(6633):569-572.